Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c661 |
|---|---|
| Identifier | NCT06257875 |
| Trial Title | A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Lutikizumab|DRUG: Lutikizumab|DRUG: Adalimumab |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | Chula Vista |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2024-03-23 |
|---|---|
| Primary Completion Date | 2027-09 |
| Completion Date | 2027-09 |